Professor Usha Menon is Interim Director of the UCL EGA Institute for Women’s Health and Head of Gynaecological Cancer Research Centre, Women’s Cancer at University College London. The focus of Professor Menon’s research is risk prediction, screening and early detection of gynaecological malignancies particularly ovarian cancer. Her work includes the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), one of the largest ever individual randomised controlled trials involving over 200,000 participants, 650,000 annual screens and 2.2 million women years of follow-up; UK Familial Ovarian Cancer Screening Study (UKFOCSS), the largest ovarian cancer screening study in the high-risk population; UK Ovarian Cancer Population Study (UKOPS), a key contributor to the Ovarian Cancer Association Consortium and studies exploring symptoms and intervals to diagnosis of cancer such as International Cancer Benchmarking Partnership. She has led the set-up of the trial biobanks which have over half a million well-annotated samples and support numerous international collaborations on cancer biomarker discovery and validation. The research has attracted funding from the Medical Research Council, Cancer Research UK, National Institute for Health Research, European Union and The Eve Appeal and resulted in a UCL spin-off company Abcodia Ltd.
She is Consultant Gynaecologist at University College Hospital where her main clinical interest is management of women at risk of familial gynaecological cancer.